REVB Q4 2021 Earnings — Revelation Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

REVBRevelation Biosciences, Inc.

$2M

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$20,910

Operating Income

-$4M

Net Income

-$4M

EPS (Diluted)

$-6569.81

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$105,912

Balance Sheet

Total Assets

$2M

Total Liabilities

$2M

Stockholders' Equity

-$99,470

Cash & Equivalents

$1M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$20,910	$0	—
Operating Income	-$4M	-$3M	-33.2%
Net Income	-$4M	-$3M	-33.4%